Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 08, 2020

SELL
$62.1 - $78.08 $819,036 - $1.03 Million
-13,189 Closed
0 $0
Q2 2020

Jul 08, 2020

SELL
$72.34 - $84.0 $65,901 - $76,524
-911 Reduced 6.46%
13,189 $1.02 Million
Q1 2020

Apr 29, 2020

BUY
$62.63 - $80.22 $883,083 - $1.13 Million
14,100 New
14,100 $1.1 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Qp Wealth Management, LLC Portfolio

Follow Qp Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qp Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qp Wealth Management, LLC with notifications on news.